- Home
- Publications
- Publication Search
- Publication Details
Title
The potential utility of PFKFB3 as a therapeutic target
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume -, Issue -, Pages 1-16
Publisher
Informa UK Limited
Online
2018-07-09
DOI
10.1080/14728222.2018.1498082
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation
- (2018) Helga Simon-Molas et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor
- (2018) Yu Zhu et al. ONCOGENE
- Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis
- (2018) Fu-Long Li et al. Nature Communications
- Vessel pruning or healing: endothelial metabolism as a novel target?
- (2017) Anna Rita Cantelmo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells
- (2017) Ana Rodríguez-García et al. FEBS Journal
- By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma
- (2017) Sainan Li et al. INTERNATIONAL JOURNAL OF CANCER
- Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
- (2017) Hui-Min Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PFKFB3, a Direct Target of p63, Is Required for Proliferation and Inhibits Differentiation in Epidermal Keratinocytes
- (2017) Robert B. Hamanaka et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
- (2017) Jason A. Chesney et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer
- (2016) Julie O’Neal et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- Abstract 557: Taking the sweet out of Th17 cells to potentiate immuno-oncology drugs
- (2016) Sucheta Telang et al. CANCER RESEARCH
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Akt mediates TIGAR induction in HeLa cells following PFKFB3 inhibition
- (2016) Helga Simon-Molas et al. FEBS LETTERS
- TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia
- (2016) Sixuan Qian et al. Journal of Hematology & Oncology
- PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense
- (2016) Hui Jiang et al. JOURNAL OF IMMUNOLOGY
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
- (2016) Wei Zhu et al. PLoS One
- p53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway
- (2016) Derek A. Franklin et al. Scientific Reports
- Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
- (2015) Na Xie et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- HIF-1 and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages
- (2015) A. Tawakol et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting
- (2015) Xin Ge et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer
- (2015) JUN HAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3
- (2015) Scott Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells
- (2015) JING-YU DU et al. ONCOLOGY REPORTS
- Clinical development of cancer therapeutics that target metabolism
- (2015) B.F. Clem et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells
- (2015) Artur Cieślar-Pobuda et al. Oncotarget
- Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase
- (2014) Isabelle Gerin et al. BIOCHEMICAL JOURNAL
- Estradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase (PFKFB3)
- (2014) Yoannis Imbert-Fernandez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
- (2014) A Yalcin et al. Cell Death & Disease
- Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
- (2014) Takehiro Yamamoto et al. Nature Communications
- PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli
- (2013) Laura Novellasdemunt et al. BIOCHEMICAL JOURNAL
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Incomplete and transitory decrease of glycolysis
- (2013) Sandra Schoors et al. CELL CYCLE
- Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
- (2013) Sandra Schoors et al. Cell Metabolism
- PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer
- (2013) Minsuh Seo et al. JOURNAL OF MOLECULAR BIOLOGY
- Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
- (2013) B. F. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondrial Dysfunction in Cancer
- (2013) Michelle L. Boland et al. Frontiers in Oncology
- Sertoli-secreted FGF-2 induces PFKFB4 isozyme expression in mouse spermatogenic cells by activation of the MEK/ERK/CREB pathway
- (2012) Marta Gómez et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State
- (2012) Isabel Garcia-Cao et al. CELL
- Anticancer Agents That Counteract Tumor Glycolysis
- (2012) Carlotta Granchi et al. ChemMedChem
- Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses
- (2012) Yuqing Huo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation
- (2012) Sucheta Telang et al. Journal of Translational Medicine
- Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells
- (2011) Laura Novellasdemunt et al. BIOCHEMICAL JOURNAL
- Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner
- (2011) Min Sup Song et al. CELL
- LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas
- (2011) Michael Fleischer et al. GENES CHROMOSOMES & CANCER
- Cooperation of Adenosine with Macrophage Toll-4 Receptor Agonists Leads to Increased Glycolytic Flux through the Enhanced Expression ofPFKFB3Gene
- (2011) Almudena Ruiz-García et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity
- (2011) M M Reddy et al. LEUKEMIA
- Block Copolymer Micelles for Controlled Delivery of Glycolytic Enzyme Inhibitors
- (2011) Shanjida Akter et al. PHARMACEUTICAL RESEARCH
- Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect
- (2011) Minsuh Seo et al. PLoS One
- Molecular basis of the fructose-2,6-bisphosphatase reaction of PFKFB3: Transition state and the C-terminal function
- (2011) Michael C. Cavalier et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells
- (2011) Miguel A. Peña-Rico et al. RADIOTHERAPY AND ONCOLOGY
- The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia
- (2010) Manuel J. Del Rey et al. ARTHRITIS AND RHEUMATISM
- Interleukin 6 Enhances Glycolysis through Expression of the Glycolytic Enzymes Hexokinase 2 and 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-3
- (2010) Masaru Ando et al. JOURNAL OF NIPPON MEDICAL SCHOOL
- Switches in 6-phosphofructo-2-kinase isoenzyme expression during rat sperm maturation
- (2009) M. Gómez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
- (2009) Abdullah Yalcin et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Pfkfb3is transcriptionally upregulated in diabetic mouse liver through proliferative signals
- (2009) Joan Duran et al. FEBS Journal
- Common and different genetic background for rheumatoid arthritis and coeliac disease
- (2009) Marieke J.H. Coenen et al. HUMAN MOLECULAR GENETICS
- Disruption of Inducible 6-Phosphofructo-2-kinase Ameliorates Diet-induced Adiposity but Exacerbates Systemic Insulin Resistance and Adipose Tissue Inflammatory Response
- (2009) Yuqing Huo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1
- (2009) Angel Herrero-Mendez et al. NATURE CELL BIOLOGY
- The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells
- (2009) K. Zscharnack et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Probing the location and function of the conserved histidine residue of phosphoglucose isomerase by using an active site directed inhibitor N-bromoacetylethanolamine phosphate
- (2009) Menghsiao Meng et al. PROTEIN SCIENCE
- Characterization of a new liver- and kidney-specific pfkfb3 isozyme that is downregulated by cell proliferation and dedifferentiation
- (2008) Joan Duran et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glycolytic enzyme inhibitors in cancer treatment
- (2008) Roberto Scatena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Association analysis of positional obesity candidate genes based on integrated data from transcriptomics and linkage analysis
- (2008) H Jiao et al. INTERNATIONAL JOURNAL OF OBESITY
- Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)
- (2008) Hua Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
- (2008) B. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of ubiquitous 6-phosphofructo-2-kinase in the liver of transgenic mice results in weight gain
- (2007) Joan Duran et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now